-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Cap-dependent-endonuclease-IN-23
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/2741952-36-1.gif)
| Category | Influenza Virus |
| CAS | 2741952-36-1 |
| Description | Cap-dependent endonuclease-IN-23 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-23 inhibits the replication of influenza virus. Cap-dependent endonuclease-IN-23 has the potential for the research of influenza virus infection (influenza A). |
Product Information
| Synonyms | Cap-dependent endonuclease-IN-23|HY-144067|CS-0375180 |
| Molecular Weight | 527.47 |
| Molecular Formula | C26H23F2N3O7 |
| Canonical SMILES | CN1C2CCOC3=CC(=C(C=C3C(N2N4C=CC(=O)C(=C4C1=O)OCOC(=O)OC)C5=CC=CC=C5)F)F |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 1000 |
| Exact Mass | 527.15040641 |
| Target | Influenza Virus |
| XLogP3-AA | 4.2 |